Overview

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
To assess the effect of long-term treatment by Genotonorm on linear growth
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Hormones